Birdwatch Note
2024-05-08 01:40:55 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
AZ señala que las razones del cese de la comercialización de la vacuna es debido a cuestiones comerciales (baja demanda y excedente). Los efectos secundarios (trombosis) los conocemos desde 2021 y no son la motivación de dicho cese https://www-heraldo-es.cdn.ampproject.org/v/s/www.heraldo.es/noticias/salud/2024/05/06/astrazeneca-deja-comercializar-vacuna-covid-europa-1731568.amp.html?amp_gsa=1&amp_js_v=a9&usqp=mq331AQIUAKwASCAAgM%3D#amp_tf=De%20%251%24s&aoh=17151317055207&referrer=https%3A%2F%2Fwww.google.com&ampshare=https%3A%2F%2Fwww.heraldo.es%2Fnoticias%2Fsalud%2F2024%2F05%2F06%2Fastrazeneca-deja-comercializar-vacuna-covid-europa-1731568.html https://diariofarma.com/2024/05/06/la-comision-europea-suspende-la-comercializacion-de-la-vacuna-covid-de-az
Written by 30B95104D81EA6F3818A57ECB62DBE4E8CEDB0F06369B733AEE807FC55E99644
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1787947325413093820
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1788021228617314805
- noteId - 1788021228617314805
- participantId -
- noteAuthorParticipantId - 30B95104D81EA6F3818A57ECB62DBE4E8CEDB0F06369B733AEE807FC55E99644 Participant Details
- createdAtMillis - 1715132455389
- tweetId - 1787947325413093820
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- AZ señala que las razones del cese de la comercialización de la vacuna es debido a cuestiones comerciales (baja demanda y excedente). Los efectos secundarios (trombosis) los conocemos desde 2021 y no son la motivación de dicho cese https://www-heraldo-es.cdn.ampproject.org/v/s/www.heraldo.es/noticias/salud/2024/05/06/astrazeneca-deja-comercializar-vacuna-covid-europa-1731568.amp.html?amp_gsa=1&amp_js_v=a9&usqp=mq331AQIUAKwASCAAgM%3D#amp_tf=De%20%251%24s&aoh=17151317055207&referrer=https%3A%2F%2Fwww.google.com&ampshare=https%3A%2F%2Fwww.heraldo.es%2Fnoticias%2Fsalud%2F2024%2F05%2F06%2Fastrazeneca-deja-comercializar-vacuna-covid-europa-1731568.html https://diariofarma.com/2024/05/06/la-comision-europea-suspende-la-comercializacion-de-la-vacuna-covid-de-az
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-05-08 01:40:55 UTC (1715132455389) |
2024-05-08 11:00:25 UTC (1715166025467) |
CURRENTLY_RATED_HELPFUL | 2024-05-10 03:21:20 UTC (1715311280526) |
CURRENTLY_RATED_HELPFUL | 2024-05-08 11:00:25 UTC (1715166025467) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-05-08 15:43:45 -0500 | Rating Details | |
| 2024-05-08 15:43:14 -0500 | Rating Details | |
| 2024-05-08 13:06:51 -0500 | Rating Details | |
| 2024-05-08 11:09:53 -0500 | Rating Details | |
| 2024-05-08 10:05:06 -0500 | Rating Details | |
| 2024-05-08 09:59:32 -0500 | Rating Details | |
| 2024-05-08 09:48:01 -0500 | Rating Details | |
| 2024-05-08 09:37:49 -0500 | Rating Details | |
| 2024-05-08 09:34:50 -0500 | Rating Details | |
| 2024-05-08 09:03:15 -0500 | Rating Details | |
| 2024-05-08 08:56:59 -0500 | Rating Details | |
| 2024-05-08 08:09:00 -0500 | Rating Details | |
| 2024-05-08 07:51:41 -0500 | Rating Details | |
| 2024-05-08 06:56:10 -0500 | Rating Details | |
| 2024-05-08 06:46:54 -0500 | Rating Details | |
| 2024-05-08 06:39:30 -0500 | Rating Details | |
| 2024-05-08 05:18:27 -0500 | Rating Details | |
| 2024-05-08 01:12:48 -0500 | Rating Details | |
| 2024-05-08 00:58:10 -0500 | Rating Details | |
| 2024-05-08 00:35:55 -0500 | Rating Details | |
| 2024-05-07 23:38:21 -0500 | Rating Details | |
| 2024-05-07 23:02:52 -0500 | Rating Details | |
| 2024-05-07 21:32:41 -0500 | Rating Details | |
| 2024-05-07 21:29:37 -0500 | Rating Details | |
| 2024-05-07 21:09:42 -0500 | Rating Details | |
| 2024-05-08 15:28:58 -0500 | Rating Details | |
| 2024-05-08 13:09:13 -0500 | Rating Details | |
| 2024-05-08 13:08:11 -0500 | Rating Details | |
| 2024-05-08 12:33:32 -0500 | Rating Details | |
| 2024-05-08 12:29:34 -0500 | Rating Details | |
| 2024-05-08 12:19:58 -0500 | Rating Details | |
| 2024-05-08 12:11:58 -0500 | Rating Details | |
| 2024-05-08 12:02:00 -0500 | Rating Details | |
| 2024-05-08 12:00:47 -0500 | Rating Details | |
| 2024-05-08 10:45:58 -0500 | Rating Details | |
| 2024-05-08 06:16:56 -0500 | Rating Details | |
| 2024-05-08 06:04:52 -0500 | Rating Details | |
| 2024-05-08 05:52:27 -0500 | Rating Details | |
| 2024-05-08 05:35:36 -0500 | Rating Details | |
| 2024-05-08 04:01:36 -0500 | Rating Details | |
| 2024-05-08 03:26:59 -0500 | Rating Details | |
| 2024-05-08 01:30:40 -0500 | Rating Details | |
| 2024-05-08 01:28:26 -0500 | Rating Details | |
| 2024-05-08 01:05:50 -0500 | Rating Details | |
| 2024-05-08 00:57:22 -0500 | Rating Details | |
| 2024-05-08 00:43:34 -0500 | Rating Details | |
| 2024-05-08 00:36:37 -0500 | Rating Details | |
| 2024-05-07 23:37:38 -0500 | Rating Details | |
| 2024-05-07 23:13:46 -0500 | Rating Details | |
| 2024-05-07 22:06:21 -0500 | Rating Details | |
| 2024-05-07 21:56:22 -0500 | Rating Details | |
| 2024-05-07 21:52:04 -0500 | Rating Details | |
| 2024-05-09 08:23:19 -0500 | Rating Details | |
| 2024-05-08 12:46:47 -0500 | Rating Details | |
| 2024-05-08 12:10:42 -0500 | Rating Details | |
| 2024-05-08 09:27:16 -0500 | Rating Details | |
| 2024-05-08 09:17:59 -0500 | Rating Details | |
| 2024-05-08 07:17:59 -0500 | Rating Details | |
| 2024-05-08 05:31:44 -0500 | Rating Details | |
| 2024-05-08 04:43:13 -0500 | Rating Details | |
| 2024-05-08 04:07:13 -0500 | Rating Details | |
| 2024-05-08 03:26:19 -0500 | Rating Details | |
| 2024-05-08 02:44:01 -0500 | Rating Details | |
| 2024-05-08 02:20:09 -0500 | Rating Details | |
| 2024-05-08 01:29:48 -0500 | Rating Details | |
| 2024-05-08 01:21:50 -0500 | Rating Details | |
| 2024-05-08 00:31:14 -0500 | Rating Details | |
| 2024-05-08 00:14:40 -0500 | Rating Details | |
| 2024-05-07 22:57:53 -0500 | Rating Details | |
| 2024-05-07 22:31:29 -0500 | Rating Details | |
| 2024-05-07 22:28:01 -0500 | Rating Details | |
| 2024-05-07 22:19:02 -0500 | Rating Details | |
| 2024-05-07 22:14:09 -0500 | Rating Details | |
| 2024-05-07 21:12:26 -0500 | Rating Details | |
| 2024-05-07 20:52:50 -0500 | Rating Details | |
| 2024-05-07 20:41:32 -0500 | Rating Details | |
| 2024-05-08 04:37:14 -0500 | Rating Details | |
| 2024-05-08 03:25:13 -0500 | Rating Details | |
| 2024-05-08 01:26:34 -0500 | Rating Details | |
| 2024-05-08 00:16:18 -0500 | Rating Details | |
| 2024-05-07 20:44:19 -0500 | Rating Details | |
| 2024-05-08 08:00:49 -0500 | Rating Details | |
| 2024-05-08 02:48:35 -0500 | Rating Details | |
| 2024-05-08 01:26:03 -0500 | Rating Details | |
| 2024-05-08 00:33:37 -0500 | Rating Details | |
| 2024-05-07 23:19:06 -0500 | Rating Details | |
| 2024-05-07 22:27:49 -0500 | Rating Details | |
| 2024-05-08 05:53:50 -0500 | Rating Details | |
| 2024-05-08 04:41:31 -0500 | Rating Details | |
| 2024-05-08 01:15:43 -0500 | Rating Details | |
| 2024-05-07 23:27:10 -0500 | Rating Details | |
| 2024-05-07 23:26:30 -0500 | Rating Details | |
| 2024-05-07 21:31:13 -0500 | Rating Details | |
| 2024-05-07 20:46:19 -0500 | Rating Details |